Does age affect the response to zinc therapy for diarrhoea in Bangladeshi infants?

Christa L Fischer Walker1, Robert E Black, Abdullah H Baqui

  • 1Department of International Health, Johns Hopkins Bloomberg School of Public Health, 615 North Wolfe Street, Room E5543, Baltimore, MD 21205, USA. cfischer@jhsph.edu

Insights

Zinc supplementation shows potential benefits in treating diarrhea in children. Further research is needed to confirm its effectiveness, especially in infants under six months old.

Area of Science:

  • Pediatrics
  • Nutritional Science
  • Public Health

Background:

  • Diarrhea remains a leading cause of mortality in children under five globally.
  • Zinc supplementation has been established as an effective treatment for diarrhea in children.
  • Previous studies reported the benefits of zinc for diarrhea treatment in Bangladeshi children aged 3-59 months.

Purpose of the Study:

  • To investigate the age-specific benefits of zinc for diarrhea treatment.
  • To analyze the impact of zinc on diarrhea duration, subsequent morbidity, and mortality across different age strata.

Main Methods:

  • A cluster-randomized trial was conducted in rural Bangladesh.
  • Children aged 3-59 months were included in the study.
  • Data were stratified by age groups: 3-5 months, 6-11 months, and 12-59 months.

Main Results:

  • Trends suggest potential benefits of zinc in reducing diarrhea duration and improving outcomes in all age groups.
  • Statistical significance was not detected in the younger age strata (3-5 and 6-11 months) due to small sample sizes.
  • The study highlights a possible positive effect of zinc on reducing subsequent morbidity and mortality.

Conclusions:

  • Zinc supplementation may offer benefits for treating diarrhea in children across various age groups.
  • Further research is required to establish the efficacy of zinc for diarrhea treatment in infants younger than six months.
  • Age-specific research is crucial for optimizing zinc's role in pediatric diarrhea management.

Related Concept Videos

Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents01:18

Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents

Acute diarrhea, a common gastrointestinal disturbance, is characterized by the rapid evacuation of fluid stools, leading to an excessive weight in fluid. This condition typically arises from disorders affecting intestinal water and electrolyte transport. It can be triggered by an increased osmotic load within the intestine, excessive secretion of electrolytes and water, mucosal exudation of protein and fluid, or altered intestinal motility. The primary risks of acute diarrhea are dehydration...
Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...